Ara-290

Ara-290 is a synthetic peptide derived from a fragment of the erythropoietin (EPO) protein. It is primarily studied for its potential to treat inflammatory and neurodegenerative conditions. Unlike traditional erythropoietin, Ara-290 does not stimulate red blood cell production but instead works by activating the EPOR (erythropoietin receptor) to modulate the immune system and reduce inflammation. It has shown promise in preclinical studies for its ability to alleviate pain, promote tissue repair, and reduce inflammation in conditions like neuropathy and other chronic inflammatory disorders.